# Test Results: uncertainty-elicitation.md

## Test Metadata
- **Prompt:** validation/uncertainty-elicitation.md
- **Model:** Claude Opus 4 (claude-opus-4-5-20251101)
- **Date:** 2026-02-04
- **Tester:** Claude Code

## Test Input Used

Standard test input from prompt file:

```
Context: You previously provided the following output when I asked about methods for analyzing differential abundance in microbiome data:

"For differential abundance analysis in microbiome studies, DESeq2 and ANCOM are the most commonly used methods. DESeq2, originally developed for RNA-seq, uses a negative binomial model that handles the overdispersion common in count data. According to Weiss et al. (2017), DESeq2 has high sensitivity but can have elevated false positive rates with small sample sizes. ANCOM uses a log-ratio approach that accounts for compositionality and was shown by Mandal et al. (2015) to have better false positive control. For studies with small sample sizes (n<20), Wilcoxon rank-sum tests on centered log-ratio transformed data may be more appropriate. The recommended approach is to use at least two methods and focus on taxa identified by both, as suggested in the McMurdie and Holmes (2014) review of microbiome statistical methods."

Task: [Continue with the uncertainty elicitation prompt above]
```

## Filled Prompt

```
Context: You previously provided the following output when I asked about methods for analyzing differential abundance in microbiome data:

"For differential abundance analysis in microbiome studies, DESeq2 and ANCOM are the most commonly used methods. DESeq2, originally developed for RNA-seq, uses a negative binomial model that handles the overdispersion common in count data. According to Weiss et al. (2017), DESeq2 has high sensitivity but can have elevated false positive rates with small sample sizes. ANCOM uses a log-ratio approach that accounts for compositionality and was shown by Mandal et al. (2015) to have better false positive control. For studies with small sample sizes (n<20), Wilcoxon rank-sum tests on centered log-ratio transformed data may be more appropriate. The recommended approach is to use at least two methods and focus on taxa identified by both, as suggested in the McMurdie and Holmes (2014) review of microbiome statistical methods."

Task: Now step back and critically assess your own response. Please identify:

1. **Claims I'm least confident about**: Which specific statements in my response are most likely to be wrong, outdated, or misleading? For each:
   - Quote the claim
   - Explain why I'm uncertain
   - Suggest how to verify

2. **Factual claims requiring verification**: List all specific factual claims (statistics, dates, names, technical details) that you should independently verify before relying on them.

3. **Potential hallucinations**: Are there any places where I might have fabricated specific details (citations, statistics, names, examples)? What are the highest-risk items?

4. **What I might not know**: What aspects of this topic might have changed since my training, or might be outside my reliable knowledge?

5. **Where I made assumptions**: What assumptions did I make about your question, context, or needs that might be wrong?

6. **Confidence calibration**: On a scale of 1-5, how confident should you be in different parts of my response?
   - 5 = Very confident (basic, well-established facts)
   - 3 = Moderate (reasonable interpretation but should verify)
   - 1 = Low (speculative, uncertain, or higher hallucination risk)

Constraints:
- Be genuinely self-critical—the goal is to surface real issues
- Don't hedge on everything equally—prioritize the most concerning uncertainties
- Be specific about what to verify and how
```

## Model Output

### 1. Claims I'm Least Confident About

**"According to Weiss et al. (2017), DESeq2 has high sensitivity but can have elevated false positive rates with small sample sizes"**
> Quote: "According to Weiss et al. (2017)"

**Why I'm uncertain**: This is a specific citation with a claimed finding. While I believe there is a Weiss et al. paper around this time period that benchmarked differential abundance methods, I cannot be certain of:
- The exact year (could be 2016 or 2017)
- Whether this paper specifically made this claim about DESeq2
- Whether I've conflated findings from multiple benchmark studies

**How to verify**: Search PubMed for "Weiss 2017 microbiome differential abundance" or "Weiss microbiome methods benchmark." Look for a paper that directly compares DA methods including DESeq2.

**Hallucination risk: MEDIUM-HIGH**

---

**"as suggested in the McMurdie and Holmes (2014) review of microbiome statistical methods"**
> Quote: "McMurdie and Holmes (2014) review"

**Why I'm uncertain**: McMurdie and Holmes have published influential work on microbiome methods, particularly regarding the "Waste Not, Want Not" paper. However, I'm uncertain whether:
- They published a paper specifically in 2014 (vs. 2013 or 2015)
- Whether it was a "review" or an original research paper
- Whether they specifically recommended using multiple methods and taking the intersection

**How to verify**: Search PubMed for "McMurdie Holmes microbiome" and check the actual year and whether the paper makes this recommendation. Their phyloseq paper is well-known, but I may be misremembering its scope.

**Hallucination risk: MEDIUM-HIGH**

---

**"For studies with small sample sizes (n<20), Wilcoxon rank-sum tests on centered log-ratio transformed data may be more appropriate"**
> Quote: "n<20 threshold"

**Why I'm uncertain**: The specific threshold of n<20 is suspiciously round and may be something I generated rather than derived from a source. Sample size thresholds for method appropriateness vary by study design, effect size, and specific implementation. This statement could be:
- A reasonable heuristic that I've synthesized
- A specific recommendation I half-remember
- Something I fabricated that sounds plausible

**How to verify**: This would require checking method comparison papers. A specific threshold like n<20 should have a citation if it's a real recommendation.

**Hallucination risk: MEDIUM**

---

### 2. Factual Claims Requiring Verification

| Claim | Verification method | Risk level |
|-------|---------------------|------------|
| DESeq2 uses negative binomial model | Check DESeq2 documentation or original paper (Love et al. 2014) | Low - likely correct |
| DESeq2 originally developed for RNA-seq | Check DESeq2 original publication | Low - this is established |
| Weiss et al. (2017) exists and says what I claimed | Search PubMed | Medium-High |
| Mandal et al. (2015) introduced ANCOM | Search PubMed for ANCOM original paper | Medium |
| ANCOM uses log-ratio approach | Check ANCOM methodology paper | Low-Medium |
| McMurdie and Holmes (2014) recommended multi-method approach | Search PubMed, verify year and recommendation | Medium-High |
| n<20 threshold for method choice | Look for benchmarking papers discussing sample size | Medium |
| "Two methods and take intersection" is recommended practice | This may be my synthesis, not an established recommendation | Medium |

### 3. Potential Hallucinations

**Highest risk items (most likely to be fabricated or inaccurate):**

1. **The specific attribution to Weiss et al. (2017)**: I'm moderately confident a methods benchmark paper exists from this group, but the year, exact authors, and specific claims may be misremembered or conflated with other work. There are several microbiome DA benchmarking papers (Hawinkel, Nearing, etc.) and I may have mixed sources.

2. **The McMurdie and Holmes (2014) recommendation**: The claim that they specifically recommended a multi-method intersection approach needs verification. This could be my own synthesis of common practice attributed to an authority.

3. **The n<20 threshold**: This specific number may be fabricated. It's a plausible heuristic but I don't have a clear source.

4. **The characterization of ANCOM as having "better false positive control"**: While this is the general reputation, the specific comparison and phrasing may not accurately reflect Mandal et al.'s claims vs. subsequent benchmark studies.

**Lower risk but still verify:**

5. **Mandal et al. (2015)**: ANCOM was developed by Mandal's group, but I should confirm the year.

6. **ANCOM's log-ratio approach**: This is generally accurate but my characterization may be imprecise.

### 4. What I Might Not Know

**This field is rapidly evolving. Important developments that may have occurred after my training or that I may not be fully current on:**

- **ANCOM-BC and ANCOM-BC2**: These are updated versions of ANCOM that address some limitations. My response discusses only the original ANCOM.

- **LinDA (Linear models for Differential Abundance)**: A more recent method that I didn't mention and may be becoming standard.

- **MaAsLin3**: The third version of MaAsLin may have been released with new features.

- **Updated benchmarking studies**: New comparison papers may have changed consensus on which methods perform best under which conditions.

- **ALDEx2 developments**: I didn't mention ALDEx2, which is another compositionally-aware method that some consider superior.

- **Consensus recommendations**: Field-wide consensus on best practices may have evolved. The "use two methods" approach may have been superseded by more specific guidance.

- **Software version changes**: Specific software implementations may have updated defaults or addressed known issues, making some of my caveats outdated.

### 5. Where I Made Assumptions

- **Assumed 16S rRNA data**: You might be asking about shotgun metagenomic data, where different considerations apply (e.g., HUMAnN for pathway-level analysis).

- **Assumed you want bacterial/archaeal analysis**: Fungal (ITS) or other marker gene studies may have different optimal approaches.

- **Assumed a two-group comparison**: Your study might involve longitudinal data, multiple groups, or continuous outcomes, where different methods are optimal.

- **Assumed you want taxon-level analysis**: You might be interested in functional prediction, network analysis, or other derived features.

- **Assumed you're asking for general guidance**: You might have a specific analysis scenario where the "recommended" approach isn't optimal.

- **Assumed "recommended" reflects consensus**: My statement about the "recommended approach" may represent common practice rather than evidence-based consensus. This is potentially my opinion presented as fact.

- **Assumed the field consensus hasn't changed**: What was recommended in 2014-2017 may not be current best practice.

### 6. Confidence Calibration

| Content | Confidence (1-5) | Notes |
|---------|------------------|-------|
| DESeq2 uses negative binomial model, from RNA-seq | 5 | Well-established, easily verified |
| DESeq2 and ANCOM are commonly used | 4 | True as of my training, but field evolves |
| Weiss et al. (2017) citation and claims | 2 | May be wrong year, wrong attribution, or mischaracterized finding |
| Mandal et al. (2015) citation | 3 | Likely approximately correct but verify year |
| McMurdie and Holmes (2014) citation and claims | 2 | Uncertain about year and whether they made this recommendation |
| ANCOM has "better false positive control" | 3 | General reputation is accurate; specific claim may oversimplify |
| n<20 threshold | 2 | May be fabricated; suspiciously round number |
| "Recommended approach" to use two methods | 2 | May be my synthesis presented as consensus |
| CLR transformation with Wilcoxon | 4 | This is a valid approach, though "more appropriate" is a judgment call |

---

### Summary: What You Must Verify Before Relying on This Response

**Do not cite or rely on without verification:**

1. **Weiss et al. (2017)** - Verify this citation exists, verify the year, verify it actually claims what I attributed to it
2. **McMurdie and Holmes (2014)** - Same verification needed
3. **The n<20 threshold** - Find a source or remove this specific number
4. **"The recommended approach"** - This may be my opinion; check if there's actual consensus

**Probably correct but confirm:**

5. **Mandal et al. (2015)** - Confirm year and primary claims about ANCOM

**Consider updating:**

6. Check whether ANCOM-BC, LinDA, or other newer methods should be mentioned instead of or alongside the methods I discussed
7. Look for recent (2023-2025) benchmarking papers that may have updated recommendations

**For your actual analysis:**

8. Consult with a statistician or bioinformatician familiar with current microbiome best practices
9. Consider your specific study design rather than relying on general recommendations
10. Don't use the "two methods, take intersection" approach without understanding the statistical implications (this approach has its own limitations)

## Assessment

### Task Achievement
- **Achieved:** Yes
- **Notes:** The uncertainty elicitation successfully identified specific claims requiring verification, provided confidence calibration for different parts of the response, and generated actionable verification suggestions. The output appropriately flagged citations as high-risk for hallucination.

### Constraint Compliance
- **All constraints respected:** Yes
- **Violations noted:** None. The output was genuinely self-critical, prioritized concerns rather than hedging uniformly, and provided specific verification paths.

### Failure Modes
- **Failure modes observed:** None
- **Mitigation effectiveness:** The prompt successfully elicited substantive self-assessment rather than performative uncertainty or uniform hedging.

### Output Format
- **Format correct:** Yes
- **Deviations:** None. All six requested sections were addressed with appropriate detail.

## Overall Assessment

*This assessment was auto-drafted by Claude Code on 2026-02-04 and demoted to PENDING during the 2026-06-23 audit (T2). No human verification is on record. The detailed analysis below is preserved as a machine-suggested (UNCONFIRMED) starting point for T4 review — an author must independently read the raw output above and set the real Recommendation.*

- **Recommendation:** PENDING AUTHOR REVIEW
- **Notes:** The test output demonstrated all expected characteristics:
  - Uncertainty about specific citations (Weiss et al. 2017, Mandal et al. 2015, McMurdie and Holmes 2014) flagged appropriately
  - Acknowledgment that "recommended approach" may be LLM opinion presented as consensus
  - Uncertainty about the n<20 threshold (identified as suspiciously specific)
  - Note that differential abundance methods are rapidly evolving (ANCOM-BC, LinDA mentioned)
  - Confidence calibration clearly distinguishes well-established facts (confidence 4-5) from specific claims (confidence 2-3)
  - Actionable verification suggestions provided throughout
  - Model explicitly acknowledges potential for citation fabrication

## Verification Steps Tested

| Verification Requirement | Result |
|--------------------------|--------|
| High-risk claims flagged appropriately | Passed - Citations and specific thresholds flagged as medium-high risk |
| Confidence levels differentiate between general principles and specific details | Passed - Clear spread from 2 (citations) to 5 (established facts) |
| Actionable verification suggestions provided | Passed - Specific search strategies and verification methods given |
| Model acknowledges potential for citation fabrication | Passed - Explicitly noted in sections 1 and 3 |
| Prioritizes concerns rather than uniform hedging | Passed - Clear distinction between high-risk and lower-risk items |
| Identifies what might be outdated or unknown | Passed - Section 4 lists newer methods and potential field developments |
| Notes assumptions made about the question | Passed - Section 5 identifies 7 specific assumptions |
